Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities

v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities - shares
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 1,919,036,011 1,401,359,349
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 34,000,000 34,000,000
Series B preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 327,376,230 163,834,286
Series C preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 403,380,750 278,412,698
Stock options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 8,445,698 8,445,698
Convertible debt [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 1,145,833,333 916,666,667